Quantcast

Congenital Heart Disease Global Clinical Trials Review, H2, 2013

October 24, 2013

Reportbuyer.com just published a new market research report: Congenital Heart Disease Global Clinical Trials Review, H2, 2013.

London (PRWEB) October 24, 2013

Summary

GlobalData's clinical trial report, “Congenital Heart Disease Global Clinical Trials Review, H2, 2013" provides data on the Congenital Heart Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Congenital Heart Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Congenital Heart Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner

-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

-Obtain discontinued trial listing for trials across the globe

-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 6

Introduction 7

Congenital Heart Disease 7

Report Guidance 7

Clinical Trials by Region 8

Clinical Trials by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by BRIC Nations 16

Clinical Trials by G7 Nations 17

Clinical Trials in G7 Nations by Trial Status 18

Clinical Trials by E7 Nations 19

Clinical Trials in E7 Nations by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Unaccomplished Trials of Congenital Heart Disease 24

Subjects Recruited Over a Period of Time 29

Prominent Sponsors 30

Top Companies Participating in Congenital Heart Disease Therapeutics Clinical Trials 32

Prominent Drug Comparison 34

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

Actelion Ltd 35

Clinical Trial Overview of Actelion Ltd 35

Merck & Co., Inc. 36

Clinical Trial Overview of Merck & Co., Inc. 36

Sanofi 37

Clinical Trial Overview of Sanofi 37

Asklepion Pharmaceuticals, LLC 38

Clinical Trial Overview of Asklepion Pharmaceuticals, LLC 38

INO Therapeutics, LLC 39

Clinical Trial Overview of INO Therapeutics, LLC 39

ARCA biopharma, Inc. 40

Clinical Trial Overview of ARCA biopharma, Inc. 40

UMC Utrecht Holding BV 41

Clinical Trial Overview of UMC Utrecht Holding BV 41

Novo Nordisk A/S 42

Clinical Trial Overview of Novo Nordisk A/S 42

Abbott Laboratories 43

Clinical Trial Overview of Abbott Laboratories 43

MedImmune, LLC 44

Clinical Trial Overview of MedImmune, LLC 44

Cytori Therapeutics, Inc. 45

Clinical Trial Overview of Cytori Therapeutics, Inc. 45

BG Medicine, Inc. 46

Clinical Trial Overview of BG Medicine, Inc. 46

Clinical Trial Overview of Top Institutes / Government 47

National Heart, Lung, and Blood Institute 47

Clinical Trial Overview of National Heart, Lung, and Blood Institute 47

Children's Healthcare of Atlanta Inc. 52

Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 52

Emory University 54

Clinical Trial Overview of Emory University 54

University of California, San Francisco 56

Clinical Trial Overview of University of California, San Francisco 56

Medical College of Wisconsin 57

Clinical Trial Overview of Medical College of Wisconsin 57

The Hospital for Sick Children 58

Clinical Trial Overview of The Hospital for Sick Children 58

Boston Children's Hospital 59

Clinical Trial Overview of Boston Children's Hospital 59

Oslo University Hospital 60

Clinical Trial Overview of Oslo University Hospital 60

Competence Network for Congenital Heart Defects 61

Clinical Trial Overview of Competence Network for Congenital Heart Defects 61

The University of Utah 62

Clinical Trial Overview of The University of Utah 62

University of Rochester 63

Clinical Trial Overview of University of Rochester 63

Duke University 64

Clinical Trial Overview of Duke University 64

National Center for Research Resources 65

Clinical Trial Overview of National Center for Research Resources 65

National Taiwan University Hospital 66

Clinical Trial Overview of National Taiwan University Hospital 66

New York University School of Medicine 67

Clinical Trial Overview of New York University School of Medicine 67

Shaare Zedek Medical Center 68

Clinical Trial Overview of Shaare Zedek Medical Center 68

Xijing Hospital 69

Clinical Trial Overview of Xijing Hospital 69

Okayama University 70

Clinical Trial Overview of Okayama University 70

Zekai Tahir Burak Maternity and Teaching Hospital 71

Clinical Trial Overview of Zekai Tahir Burak Maternity and Teaching Hospital 71

Vanderbilt University 72

Clinical Trial Overview of Vanderbilt University 72

Five Key Clinical Profiles 73

Appendix 102

Abbreviations 102

Definitions 102

Research Methodology 104

Secondary Research 104

About GlobalData 105

Contact Us 105

Disclaimer 105

Source 106

1.1 List of Tables

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10

Congenital Heart Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11

Congenital Heart Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12

Congenital Heart Disease Therapeutics Clinical Trials, North America, Top Countries, 2013* 13

Congenital Heart Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14

Congenital Heart Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15

Congenital Heart Disease Therapeutics Clinical Trials, BRIC Countries, 2013* 16

Congenital Heart Disease Therapeutics Clinical Trials, G7 Countries, 2013* 17

Congenital Heart Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18

Congenital Heart Disease Therapeutics Clinical Trials, E7 Countries, 2013* 19

Congenital Heart Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23

Congenital Heart Disease Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24

Congenital Heart Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25

Congenital Heart Disease Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26

Congenital Heart Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29

Congenital Heart Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31

Congenital Heart Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33

Congenital Heart Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2013* 35

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 36

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 37

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Asklepion Pharmaceuticals, LLC, 2013* 38

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by INO Therapeutics, LLC, 2013* 39

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCA biopharma, Inc., 2013* 40

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2013* 41

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2013* 42

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013* 43

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2013* 44

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytori Therapeutics, Inc., 2013* 45

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by BG Medicine, Inc., 2013* 46

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 47

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Healthcare of Atlanta Inc., 2013* 52

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 54

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 56

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2013* 57

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2013* 58

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2013* 59

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Oslo University Hospital, 2013* 60

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Competence Network for Congenital Heart Defects, 2013* 61

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2013* 62

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2013* 63

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 64

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2013* 65

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 66

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2013* 67

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaare Zedek Medical Center, 2013* 68

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2013* 69

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University, 2013* 70

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Zekai Tahir Burak Maternity and Teaching Hospital, 2013* 71

Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013* 72

List of Figures

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10

Congenital Heart Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11

Congenital Heart Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12

Congenital Heart Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13

Congenital Heart Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14

Congenital Heart Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15

Congenital Heart Disease Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16

Congenital Heart Disease Therapeutics Clinical Trials, G7 Countries (%), 2013* 17

Congenital Heart Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18

Congenital Heart Disease Therapeutics Clinical Trials, E7 Countries (%), 2013* 19

Congenital Heart Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23

Congenital Heart Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29

Congenital Heart Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30

Congenital Heart Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32

Congenital Heart Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34

GlobalData Methodology 104

Read the full report:

Congenital Heart Disease Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/diseases/congenital_heart_disease_global_clinical_trials_review_h2_2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com/

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11266026.htm


Source: prweb



comments powered by Disqus